1
Sodium Risedronate Tablets – Special Drug Use Surveillance in Patients With Osseous Paget’s Disease (All-case Surveillance) -48-week Surveillance –
Condition(s):Osseous Paget’s DiseaseLast Updated:June 3, 2019Completed
Risedronic Acid as an Intervention: 110 Clinical Trials, Page 1 of 11
Hide Studies Not Open or Pending
2
Prophylactic Riserodrenate for Patients With Peripheral Lung Tumors Treated With SBRT
Condition(s):Lung NeoplasmLast Updated:April 26, 2023Completed
3
Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer
Condition(s):Prostate CancerLast Updated:May 1, 2018Completed
4
Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy
Condition(s):OsteoporosisLast Updated:July 28, 2020Completed
5
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.
Condition(s):Renal Transplant OsteodystrophyLast Updated:March 1, 2019Completed
6
Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover
Condition(s):Postmenopausal Women With OsteoporosisLast Updated:November 2, 2011Completed
7
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
Condition(s):Prostate CancerLast Updated:February 3, 2012Completed
8
A Study of Monthly Risedronate for Osteoporosis
Condition(s):Postmenopausal OsteoporosisLast Updated:April 22, 2013Completed
9
36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets
Condition(s):OsteoporosisLast Updated:July 30, 2019Completed
10
Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women
Condition(s):Postmenopausal OsteoporosisLast Updated:November 30, 2022Not yet recruiting